← Leaderboards
Ananth V Annapragada
University Of Texas Hlth Sci Ctr Houston
$7,084,879
Attributed
$23,397,574
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.9M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,397,574 · 7
By mechanism
R33$6,271,251 · 1
OT2$4,853,391 · 1
U01$3,898,598 · 1
R01$3,739,326 · 2
RF1$3,039,032 · 1
R61$1,595,976 · 1
Top collaborators
- Andrew Sikora8 shared
- Karin Anneliese Fox6 shared
- Chandrasekhar Yallampalli6 shared
- Carl E Allen5 shared
- Sridevi Devaraj5 shared
- Craig G Rusin5 shared
- Nadarajah Vigneswaran4 shared
- Andrew Arun Badachhape1 shared
Most similar at University Of Texas Hlth Sci Ctr Houston
Same institution · by research overlap
- Nadarajah Vigneswaran$1,264,437
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseCellsBindingDesignChemoradiationUptakeMediatingLigandsTherapy ResistantPre-ClinicalNanoparticleCancer TherapyMouth Squamous Cell CarcinomaTreatment EfficacyCell TypeMalignant Mouth NeoplasmCancer RecurrenceChemotherapyNeoplastic CellTumorImageImmuneMethodologyMouse Model
Grant awards (25)
VALIDATE ASD: INDEPENDENT MULTIMODAL REPLICATION AND VALIDATION OF AUTISM DATA-SCIENCE MODELS$4,853,391
OT2 · FY2025 · OD
SARS-CoV-2 initiation and acceleration of AD pathology in the setting of endogenous and exogenous risk factors$3,039,032
RF1 · FY2025 · NS · contact PI
The PreVAIL-kIds Common Protocol$3,148,282
R33 · FY2023 · HD · contact PI
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids$1,565,899
R33 · FY2023 · HD · contact PI
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids$1,557,070
R33 · FY2023 · HD · contact PI
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids$778,430
R61 · FY2022 · HD · contact PI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$661,043
U01 · FY2022 · DE
Molecular and Vascular MRI of Placenta Accreta$371,724
R01 · FY2022 · HD · contact PI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$64,165
U01 · FY2022 · DE
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$21,034
U01 · FY2022 · DE
AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids$817,546
R61 · FY2021 · HD · contact PI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$745,334
U01 · FY2021 · DE
Molecular and Vascular MRI of Placenta Accreta$525,213
R01 · FY2021 · HD · contact PI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$761,749
U01 · FY2020 · DE
Molecular and Vascular MRI of Placenta Accreta$379,311
R01 · FY2020 · HD · contact PI
Molecular and Vascular MRI of Placenta Accreta$156,621
R01 · FY2020 · HD · contact PI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$776,961
U01 · FY2019 · DE
Molecular and Vascular MRI of Placenta Accreta$379,311
R01 · FY2019 · HD · contact PI
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$63,718
U01 · FY2019 · DE
Targeting the immunosuppressive tumor microenvironment to enhance efficacy of radiotherapy and immuno-radiotherapy for oral cancer$804,594
U01 · FY2018 · DE
Molecular and Vascular MRI of Placenta Accreta$379,311
R01 · FY2018 · HD · contact PI
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$383,932
R01 · FY2017 · DE
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$383,817
R01 · FY2016 · DE
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$383,621
R01 · FY2015 · DE
Aptamer mediated targeting of Fanconi Anemia oral cancer initiating cells$396,465
R01 · FY2014 · DE